Protective effect of interferon type I on barrier function of human airway epithelium during rhinovirus infections in vitro
2024

How Interferon Type I Protects Airway Cells from Rhinovirus Infections

Sample size: 4 publication 10 minutes Evidence: high

Author Information

Author(s): Boland Helena, Endres Adrian, Kinscherf Ralf, Schubert Ralf, Wilhelm Beate, Schwarzbach Hans, Jonigk Danny, Braubach Peter, Rohde Gernot

Primary Institution: Johann Wolfgang Goethe-Universität, Frankfurt am Main

Hypothesis

Can type I interferons protect against virus-induced epithelial barrier dysfunction during rhinovirus infections?

Conclusion

Interferon-β1a pre-treatment effectively protects airway epithelial cells from damage caused by rhinovirus infections.

Supporting Evidence

  • IFN-β1a pre-treatment reduced viral RNA copies by up to 99.8%.
  • HRV infection significantly damaged tight junctions in untreated cells.
  • Pre-treatment with IFN-β1a maintained barrier integrity during viral infection.
  • IFN-β1a reduced the number of dead cells in infected cultures.
  • TEER measurements showed that IFN-β1a pre-treatment prevented the drop in barrier function.

Takeaway

This study shows that a special protein called interferon can help protect the cells in our lungs from getting hurt by a virus that causes colds.

Methodology

Differentiated primary bronchial epithelial cells were pre-treated with IFN-β1a and then infected with human rhinovirus to assess barrier function and cell viability.

Limitations

The study was conducted in vitro, which may not fully replicate in vivo conditions.

Participant Demographics

Primary bronchial epithelial cells were isolated from lung explant tissue of four cystic fibrosis patients.

Statistical Information

P-Value

0.021

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/s41598-024-82516-2

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication